我如何治疗复发性/耐药性扩散性大B细胞淋巴瘤的老年患者
Danielle S Wallace1, Kah Poh Loh1, Carla Casulo1
1Division of Hematology/Oncology, Department of Medicine, Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY.
Blood
|October 2, 2024
概括
复发性扩散性大B细胞淋巴瘤 (DLBCL) 的老年患者面临治疗挑战. 这篇文章总结了使用新疗法管理这些患者的方法,考虑到健康状况和并发症.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 老年医学 老年医学
背景情况:
- 扩散性大B细胞淋巴瘤 (DLBCL) 是一种侵袭性癌症,老年人面临更高的复发风险.
- 伴随性疾病和减少强化治疗的资格使老年DLBCL患者的护理复杂化.
- 新型疗法提供了新的选择,但谨慎的患者选择和管理至关重要.
研究的目的:
- 总结老年患者复发性或耐药性DLBCL的管理策略.
- 讨论适应性评估和新型治疗选择在这个人群中的作用.
- 为老年DLBCL患者选择和管理治疗提供指导.
主要方法:
- 对老年人复发/耐药DLBCL当前治疗环境的审查.
- 讨论将老年医疗评估纳入治疗决策的讨论.
- 新型治疗方法的总结,包括CAR T细胞疗法,双特异性抗体和向性药物.
主要成果:
- 化学抗原受体T细胞疗法是适合老年患者的选择.
- 几种新型药物和组合 (例如,tafasitamab/lenalidomide,polatuzumab,loncastuximab tesirine) 显示出对老年人的潜在修改有希望.
- 老年人的评估至关重要,但在复发的情况下需要进一步指导.
结论:
- 管理复发DLBCL的老年患者需要个性化的方法,平衡新型疗法与患者健康.
- 仔细考虑并发症和治疗强度对于优化结果至关重要.
- 需要持续的研究和临床指导来完善这种脆弱人群的治疗策略.
相关概念视频
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Tumor Immunotherapy
489
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
489
Pulmonary Tuberculosis V
170
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
170
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)

